Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05272384 |
| Title | Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | National Cancer Institute (NCI) |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Alabama at Birmingham Cancer Center | SUSPENDED | Birmingham | Alabama | 35233 | United States | Details |
| University of California Davis Comprehensive Cancer Center | RECRUITING | Sacramento | California | 95817 | United States | Details |
| University of Chicago Comprehensive Cancer Center | RECRUITING | Chicago | Illinois | 60637 | United States | Details |
| UC Comprehensive Cancer Center at Silver Cross | RECRUITING | New Lenox | Illinois | 60451 | United States | Details |
| University of Chicago Medicine-Orland Park | RECRUITING | Orland Park | Illinois | 60462 | United States | Details |
| NYU Langone Hospital - Long Island | RECRUITING | Mineola | New York | 11501 | United States | Details |
| Laura and Isaac Perlmutter Cancer Center at NYU Langone | RECRUITING | New York | New York | 10016 | United States | Details |